Position in ANIK
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$4,850,970
+$65,231 QoQ
Shares Held
331,577
+0.5% QoQ
Ownership
2.48%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 134 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANIK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $4,788,152,578 across 66 Drug Manufacturers - Specialty & Generic names. ANIK ranks #35 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
13,289,622 | $954,992,236 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
996,598 | $539,986,694 | |
| 3 | VTRS |
Viatris Inc
|
32,807,906 | $520,989,547 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
11,607,196 | $393,251,799 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
2,138,777 | $360,469,474 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
11,302,057 | $278,143,622 | |
| 7 | ALKS |
Alkermes plc.
|
4,477,876 | $234,640,702 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
1,841,367 | $204,281,254 |
All Filings in ANIK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,850,970 | 331,577 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $4,785,739 | 330,051 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,128,265 | 325,522 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $3,155,400 | 335,681 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $3,398,412 | 321,211 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $4,959,869 | 329,998 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $5,312,925 | 322,778 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $8,026,610 | 324,964 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $8,639,252 | 341,068 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $8,360,740 | 329,163 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $7,226,568 | 318,913 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $5,698,171 | 305,860 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $7,661,034 | 294,882 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $8,175,578 | 284,665 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $8,158,411 | 275,622 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $6,287,983 | 264,201 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $5,832,707 | 261,322 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $6,367,393 | 253,580 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $9,294,051 | 259,393 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $11,008,697 | 258,663 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $11,041,114 | 255,050 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $9,888,026 | 242,413 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $9,640,425 | 213,001 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $7,400,473 | 209,112 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $8,758,227 | 232,129 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $6,180,003 | 213,767 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||